GRDN vs FUL
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
GRDN · Guardian Pharmacy Services$42.39 ▲ 6.32%
FUL · H.B. Fuller$49.86 ▼ 0.72%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- GRDN +42.5%
- FUL -12.6%
Head to head
| Metric | GRDN | FUL |
|---|---|---|
| Price | $42.39 | $49.86 |
| Change today | ▲ 6.32% | ▼ 0.72% |
| Market cap | $2.69B | $2.68B |
| Return, 3 months | +2.2% | -18.6% |
| Return, year to date | +40.9% | -15.1% |
| Return, 1 year | +47.2% | -12.8% |
| P/E (TTM) | 36.2 | 13.9 |
| P/B | 10.0 | 1.2 |
| P/E percentile vs own 5y | 54th | 1st |
| Dividend yield | – | 1.93% |
| Revenue growth (YoY, latest qtr) | +2.2% | +5.2% |
| Net profit growth (YoY) | +150.6% | +17.8% |
| Gross margin | 21.6% | 32.3% |
| Operating margin | 5.8% | 11.3% |
| Net margin | 4.5% | 5.6% |
| Return on equity | 31.7% | 9.6% |
| Analyst target vs. price | +17.4% | +24.7% |
| Analyst buy share | 100% | 80% |
| RSI (14) | 57 | 47 |
| 30-day volatility | 42.3% | 29.0% |
| Max drawdown, 1 year | -18.8% | -27.0% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- GRDN is the largest of the group by market value.
- GRDN has returned the most over the past year.
- FUL carries the lowest trailing P/E.
- FUL is growing revenue fastest.
- FUL keeps the most profit per dollar of sales.
- FUL has been the calmest stock over the last 30 days.